Serum SUR1 and TRPM4 in patients with subarachnoid hemorrhage.


Journal

Neurosurgical review
ISSN: 1437-2320
Titre abrégé: Neurosurg Rev
Pays: Germany
ID NLM: 7908181

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 25 08 2019
accepted: 24 10 2019
revised: 18 10 2019
pubmed: 11 11 2019
medline: 1 5 2021
entrez: 11 11 2019
Statut: ppublish

Résumé

Neuroinflammation plays an important role in neuronal injury after aneurysmal subarachnoid hemorrhage (aSAH). Sulfonylurea receptor 1 (SUR1) and transient receptor potential cation channel subfamily M member 4 (TRPM4) receptors play an important role in the pathogenesis of several neural injuries, such as neural edema, spinal cord damage, stroke, and neuronal damage in aSAH. This study aimed to investigate the relationship of serum SUR1 and TRPM4 levels with the neurological status within the first 15 days after aSAH. In this prospective study, blood samples were collected from 44 consecutive patients on the 1st, 4th, and 14th days after aSAH. Serum SUR1 and TRPM4 levels were measured using an enzyme-linked immunosorbent assay kit. Glasgow coma scale and World Federation of Neurosurgical Societies (WFNS) scores upon presentation and Glasgow outcome scale (GOS) score on the 14th day were recorded. Serum SUR1 and TRPM4 levels on the 1st, 4th, and 14th days were significantly higher in patients with aSAH than in normal individuals. This increase in the levels varied among the 1st, 4th, and 14th days. On the first day, a correlation was observed between serum SUR1, but not TRPM4, levels and the WFNS score. Moreover, on the 14th day, an association of serum SUR1 and TRPM4 levels with the GOS score was noted. Serum SUR1 and TRPM4 levels were significantly upregulated in the peripheral blood samples. Further study is warranted to establish the utility of SUR1 and TRPM4 as biomarkers in patients with aSAH.

Identifiants

pubmed: 31707576
doi: 10.1007/s10143-019-01200-6
pii: 10.1007/s10143-019-01200-6
doi:

Substances chimiques

ABCC8 protein, human 0
Sulfonylurea Receptors 0
TRPM Cation Channels 0
TRPM4 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1595-1603

Subventions

Organisme : Bezmiâlem Vakif Üniversitesi
ID : 18245212-108.99

Références

Abdallah A, Asiltürk M, Emel E, Güler Abdallah B (2018) Factors affecting the outcome of multiple intracranial aneurysm surgery. Indian J Neurosurg 7(2):116–121
doi: 10.1055/s-0038-1668493
Asiltürk M, Abdallah A (2018) Clinical outcomes of multiple aneurysms microsurgical clipping: evaluation of 90 patients. Neurol Neurochir Pol 52(1):15–24
doi: 10.1016/j.pjnns.2017.09.005
Bailes JE, Spetzler RF, Hadley MN, Baldwin HZ (1990) Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 72:559–566
doi: 10.3171/jns.1990.72.4.0559
Caffes N, Kurland DB, Gerzanich V, Simard JM (2015) Glibenclamide for the treatment of ischemic and hemorrhagic stroke. Int J Mol Sci 16(3):4973–4984
doi: 10.3390/ijms16034973
Chalouhi N, Ali MS, Jabbour PM et al (2012) Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab 32(9):1659–1676
doi: 10.1038/jcbfm.2012.84
Dündar TT, Aralaşmak A, Özdemir H et al (2018) Comparison of TOF MRA, contrast-enhanced MRA and subtracted CTA from CTP in residue evaluation of treated intracranial aneurysms. Turk Neurosurg 28(4):563–570
Fung C, Inglin F, Murek M et al (2016) Reconsidering the logic of World Federation of Neurosurgical Societies grading in patients with severe subarachnoid hemorrhage. J Neurosurg 124(2):299–304
doi: 10.3171/2015.2.JNS14614
Gerzanich V, Kwon MS, Woo SK, Ivanov A, Simard JM (2018) SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells. PLoS One 13(4):1–23
doi: 10.1371/journal.pone.0195526
Gotoh O, Tamura A, Yasui N, Suzuki A, Hadeishi H, Sano K (1996) Glasgow Coma Scale in the prediction of outcome after early aneurysm surgery. Neurosurgery 39(1):19–25
doi: 10.1097/00006123-199607000-00005
Grasso G, Alafaci C, Macdonald RL (2017) Management of aneurysmal subarachnoid hemorrhage: state of the art and future perspectives. Surg Neurol Int 8:11
doi: 10.4103/2152-7806.198738
Haug T, Sorteberg A, Finset A, Lindegaard KF, Lundar T, Sorteberg W (2010) Cognitive functioning and health-related quality of life 1 year after aneurysmal subarachnoid hemorrhage in preoperative comatose patients (Hunt and Hess Grade V patients). Neurosurgery 66:475–485
doi: 10.1227/01.NEU.0000365364.87303.AC
Ironside N, Buell TJ, Chen CJ et al (2019) High-grade aneurysmal subarachnoid hemorrhage: predictors of functional outcome. World Neurosurg:e723–e728
Kurland DB, Tosun C, Pampori A et al (2013) Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel) 6(10):1287–1303
doi: 10.3390/ph6101287
Le Roux PD, Elliott JP, Newell DW, Grady MS, Winn HR (1996) Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 85:39–49
doi: 10.3171/jns.1996.85.1.0039
Lucke-Wold BP, Logsdon AF, Manoranjan B et al (2016) Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review. Int J Mol Sci 17:497–509
doi: 10.3390/ijms17040497
Navratil O, Duris K, Juran V, Neuman E, Svoboda K, Smrcka M (2017) Middle cerebral artery aneurysms with intracerebral hematoma—the impact of side and volume on final outcome. Acta Neurochir 159(3):543–547
doi: 10.1007/s00701-016-3070-3
Oliveira AM, Paiva WS, Figueiredo EG, Oliveira HA, Teixeira MJ (2011) Fisher revised scale for assessment of prognosis in patients with subarachnoid hemorrhage. Arq Neuropsiquiatr 69(6):910–913
doi: 10.1590/S0004-282X2011000700012
Scharbrodt W, Stein M, Schreiber V, Böker DK, Oertel MF (2009) The prediction of long-term outcome after subarachnoid hemorrhage as measured by the Short Form-36 Health Survey. J Clin Neurosci 16(11):1409–1413
doi: 10.1016/j.jocn.2009.01.011
Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, Gerzanich V (2009) Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 29(2):317–330
doi: 10.1038/jcbfm.2008.120
Simard JM, Kahle KT, Gerzanich V (2010) Molecular mechanisms of microvascular failure in central nervous system injury--synergistic roles of NKCC1 and SUR1/TRPM4. J Neurosurg 113:622–629
doi: 10.3171/2009.11.JNS081052
Tosun C, Kurland DB, Mehta R, Castellani RJ, deJong J, Kwon MS, Woo SK, Gerzanich V, Simard JM (2013) Inhibition of the SUR1-TRPM4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke. 44(12):3522–3528
doi: 10.1161/STROKEAHA.113.002904
Woo SK, Kwon MS, Ivanov A, Gerzanich V, Simard JM (2013) The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J Biol Chem 288:3655–3667
doi: 10.1074/jbc.M112.428219
Wostrack M, Sandow N, Vajkoczy P, Schatlo B, Bijlenga P, Schaller K, Kehl V, Harmening K, Ringel F, Ryang YM, Friedrich B, Stoffel M, Meyer B (2013) Subarachnoid haemorrhage WFNS grade V: is maximal treatment worthwhile? Acta Neurochir 155:579–586
doi: 10.1007/s00701-013-1634-z
Zhang G, Lin X, Zhang S, Xiu H, Pan C, Cui W (2017) A protective role of Glibenclamide in inflammation-associated injury Mediators Inflamm Article ID: 3578702, 11 pages
Zhang Y, Hu Q, Xue H et al (2017) Intrasylvian/intracerebral hematomas associated with ruptured middle cerebral artery aneurysms: a single-center series and literature review. World Neurosurg 98:432–437
doi: 10.1016/j.wneu.2016.11.022
Zhao C, Wei Y (2017) Surgical timing for aneurysmal subarachnoid hemorrhage: A meta-analysis and systematic review. Turk Neurosurg 27(4):489–499
pubmed: 27759872
Zheng VZ, Wong GKC (2017) Neuroinflammation responses after subarachnoid hemorrhage: a review. J Clin Neurosci 42:7–11
doi: 10.1016/j.jocn.2017.02.001

Auteurs

Tolga Turan Dundar (TT)

Department of Neurosurgery, Bezmialem Vakif University, Adnan Menderes Bulvari, Vatan Street, 34093, Fatih, Istanbul, Turkey. tdundar@bezmialem.edu.tr.

Anas Abdallah (A)

Department of Neurosurgery, Bezmialem Vakif University, Adnan Menderes Bulvari, Vatan Street, 34093, Fatih, Istanbul, Turkey.

Ismail Yurtsever (I)

Department of Radiology, Bezmialem Vakif University, 34093, Istanbul, Turkey.

Eray Metin Guler (EM)

Department of Biochemistry, Bezmialem Vakif University, 34093, Istanbul, Turkey.

Omer Faruk Ozer (OF)

Department of Biochemistry, Bezmialem Vakif University, 34093, Istanbul, Turkey.

Omer Uysal (O)

Department of Biostatistics, Bezmialem Vakif University, 34093, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH